Osaic Holdings’s Serina Therapeutics SER Stock Holding History

Osaic Holdings’s Portfolio SER Stock Details SER Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.88K	Buy	2,002 +1,001	+100%	+$1.88K	﹤0.01%	7051
2026 Q1	$1.94K	Buy	1,001 +999	+49,950%	+$2.2K	﹤0.01%	7058
2025 Q4	$2	Sell	2 -9	-82%	-$36	﹤0.01%	7807
2025 Q3	$54	Hold	11	–	–	﹤0.01%	7783
2025 Q2	$67	Buy	11 +1	+10%	+$6	﹤0.01%	7594
2025 Q1	$55	Buy	10 +5	+100%	+$24	﹤0.01%	7278
2024 Q4	$25	Sell	5 -5	-50%	-$30	﹤0.01%	7317
2024 Q3	$66	Sell	10 -1	-9%	-$8	﹤0.01%	7279
2024 Q2	$103	Buy	11 +4	+57%	+$39	﹤0.01%	7241
2024 Q1	$89	Sell	7 -85	-92%	-$1.19K	﹤0.01%	7047
2023 Q4	$1.24K	Sell	92 -4	-4%	-$74	﹤0.01%	6675
2023 Q3	$2.3K	Buy	96 +4	+4%	+$106	﹤0.01%	6581
2023 Q2	$2.89K	Sell	92 -1	-1%	-$21	﹤0.01%	6533
2023 Q1	$2.18K	Hold	93	–	–	﹤0.01%	6676
2022 Q4	$2K	Hold	93	–	–	﹤0.01%	6722
2022 Q3	$2K	Hold	93	–	–	﹤0.01%	6855
2022 Q2	$2K	Hold	93	–	–	﹤0.01%	6952
2022 Q1	$6K	Sell	93 -1	-1%	-$28	﹤0.01%	6423
2021 Q4	$3K	Hold	94	–	–	﹤0.01%	6923
2021 Q3	$3K	Hold	94	–	–	﹤0.01%	6779
2021 Q2	$5K	Hold	94	–	–	﹤0.01%	6391
2021 Q1	$5K	Hold	94	–	–	﹤0.01%	6184
2020 Q4	$5K	Sell	94 -3	-3%	-$173	﹤0.01%	5804
2020 Q3	$2K	Buy	97 +3	+3%	+$107	﹤0.01%	5905
2020 Q2	$3K	Hold	94	–	–	﹤0.01%	5706
2020 Q1	$3K	Buy	+94	New	+$4.42K	﹤0.01%	5590

Other funds holding SER

Sio Capital Management New York $604M AUM 96.57% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Waverly Advisors Birmingham, Alabama $17.2B AUM 24.89% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Keel Point Huntsville, Alabama $1.69B AUM 20.79% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Avidian Wealth Enterprises Houston, Texas $3.59B AUM 17.8% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Osaic Holdings's SER Position: Q2 2026 in Review

Osaic Holdings increased its Serina Therapeutics (SER) stake by 100% in Q2 2026, buying an estimated $1.88K and bringing the position to 2,002 shares worth $3.88K. The position accounts for ﹤0.01% of the portfolio, ranked #7051.

Osaic Holdings first reported a position in SER in Q1 2020 and has held it in 26 quarters since. The position peaked at $6K in Q1 2022. 27 funds tracked by Wall St. Rank hold SER as of Q2 2026.

Osaic Holdings held 2,002 shares of Serina Therapeutics worth $3.88K as of Q2 2026.
Osaic Holdings bought 1,001 Serina Therapeutics shares in Q2 2026, an estimated $1.88K.
Serina Therapeutics made up ﹤0.01% of Osaic Holdings's portfolio in Q2 2026, its #7051 holding.
Osaic Holdings first reported a position in Serina Therapeutics in Q1 2020 and has held it in 26 quarters since.
Osaic Holdings's Serina Therapeutics position peaked at $6K in Q1 2022.
27 funds tracked by Wall St. Rank held Serina Therapeutics as of Q2 2026.

Based on Osaic Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.